In Depth 3 Oct 2025 The biggest biotech funding rounds in September 2025 uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025. October 3, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 3 Oct 2025Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round. October 3, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 1 Oct 2025 Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. October 1, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2025 Asthma study suggests lung scarring may be reversible Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible. October 1, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies. September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by AseBio 29 Sep 2025 Destination BIOSPAIN 2025: What you need to know about Spain’s flagship event for biotech BIOSPAIN 2025 returns to Barcelona, bringing 2,200+ biotech professionals for networking, collaborations, and industry insights. September 29, 2025 - 6 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2025 Can biotechnology reduce animal testing in medicine? Animal testing is crucial for measuring the efficacy and safety of new treatments. It is also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let […] September 26, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 26 Sep 2025What’s next in immunology & inflammation R&D: The trends to watch This week’s guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape September 26, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 24 Sep 2025 Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity? Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns? September 24, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2025 Eli Lilly’s strategy in motion: Beyond diabetes and obesity Delve into a biopharma giant’s strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. September 24, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Sep 2025 Navigating German biotech: 14 key players to know The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies. September 23, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email